Suppr超能文献

慢性阻塞性肺疾病患者的鼻纤毛摆动减弱。

Ciliary beating is depressed in nasal cilia from chronic obstructive pulmonary disease subjects.

机构信息

Department of Medicine, McMaster University, Hamilton, ON, Canada.

出版信息

Respir Med. 2012 Aug;106(8):1139-47. doi: 10.1016/j.rmed.2012.04.001. Epub 2012 May 17.

Abstract

UNLABELLED

COPD is characterized by increased cough, mucus production, and airway inflammation. Beating epithelial cell cilia contribute to mucociliary clearance with ciliary beat frequency (CBF) an important measure of cilia function. However, whether CBF varies with COPD severity is unknown.

AIMS

  1. to compare nasal cilia samples and their CBF from healthy non-smokers (Control), COPD and At Risk (cough and sputum production) subjects. 2) to determine the effect of pharmacologic agents that modulate mediators implicated in the pathogenesis of COPD on nasal CBF. Nasal brushings of ciliated cells were obtained from Control, At Risk and COPD subjects. Using high speed digital imaging, we measured baseline CBF ex vivo. Then, CBF was re-measured after 30 min perfusion with pharmacologic agents that modulate mediators implicated in COPD (salmeterol xinafoate, tiotropium bromide, licofelone, luteolin, YM976, Defensin HNP-1) and again after 30 min washout. CBF was significantly depressed in moderate and severe COPD compared to At Risk and Control subjects. There was an evident and persistent rise in CBF with all agents tested in COPD cilia except that YM976 effects persisted only in severe COPD. Only YM976 and tiotropium caused a persistent increase in CBF in At Risk cilia. The reduction of nasal CBF in moderate and severe COPD implies that impaired ciliary function may impact mucociliary clearance in COPD, potentially contributing to retention of secretions and infection. Pharmacologic agents with different mechanisms of action can increase CBF of COPD cilia. Further investigation of the signalling pathways influencing CBF of COPD cilia is needed.
摘要

目的

1)比较健康非吸烟者(对照组)、COPD 和有风险(咳嗽和咳痰)患者的鼻纤毛样本及其纤毛摆动频率(CBF)。2)确定调节 COPD 发病机制中涉及的介质的药物对鼻 CBF 的影响。从对照组、有风险和 COPD 患者中获取鼻刷纤毛细胞。使用高速数字成像,我们测量了体外的基线 CBF。然后,在 30 分钟内用调节 COPD 涉及的介质的药物(沙美特罗辛萘酸酯、噻托溴铵、利福昔明、木樨草素、YM976、防御素 HNP-1)灌注后重新测量 CBF,并在 30 分钟冲洗后再次测量 CBF。与有风险和对照组相比,中重度 COPD 患者的 CBF 明显降低。除 YM976 仅在重度 COPD 中持续作用外,所有在 COPD 纤毛中测试的药物均导致 CBF 明显升高。仅 YM976 和噻托溴铵导致有风险的纤毛 CBF 持续增加。中重度 COPD 鼻 CBF 降低意味着纤毛功能受损可能影响 COPD 的黏液纤毛清除功能,从而导致分泌物潴留和感染。具有不同作用机制的药物可增加 COPD 纤毛的 CBF。需要进一步研究影响 COPD 纤毛 CBF 的信号通路。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验